CN1279612A - 免疫应答的调制 - Google Patents

免疫应答的调制 Download PDF

Info

Publication number
CN1279612A
CN1279612A CN98810397A CN98810397A CN1279612A CN 1279612 A CN1279612 A CN 1279612A CN 98810397 A CN98810397 A CN 98810397A CN 98810397 A CN98810397 A CN 98810397A CN 1279612 A CN1279612 A CN 1279612A
Authority
CN
China
Prior art keywords
chemical compound
animal
disease
alkyl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98810397A
Other languages
English (en)
Chinese (zh)
Inventor
C·J·兰多尔
G·J·杜普瑞兹
V·R·施拉克
D·C·阿特费尔德
J·B·范丹伯加尔丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANGOLD HOLDINGS LTS
Original Assignee
FRANGOLD HOLDINGS LTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANGOLD HOLDINGS LTS filed Critical FRANGOLD HOLDINGS LTS
Publication of CN1279612A publication Critical patent/CN1279612A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN98810397A 1997-09-16 1998-09-16 免疫应答的调制 Pending CN1279612A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA978319 1997-09-16
ZA97/8319 1997-09-16

Publications (1)

Publication Number Publication Date
CN1279612A true CN1279612A (zh) 2001-01-10

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98810397A Pending CN1279612A (zh) 1997-09-16 1998-09-16 免疫应答的调制

Country Status (10)

Country Link
EP (1) EP1019063A4 (fr)
JP (1) JP2001516721A (fr)
CN (1) CN1279612A (fr)
AU (1) AU737867B2 (fr)
BR (1) BR9812321A (fr)
CA (1) CA2304119A1 (fr)
IL (1) IL135091A0 (fr)
NO (1) NO20001341L (fr)
NZ (1) NZ503418A (fr)
WO (1) WO1999013885A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (fr) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited Substance ou composition pour le traitement du cancer
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Also Published As

Publication number Publication date
WO1999013885A1 (fr) 1999-03-25
CA2304119A1 (fr) 1999-03-25
IL135091A0 (en) 2001-05-20
NO20001341L (no) 2000-05-16
JP2001516721A (ja) 2001-10-02
AU9389098A (en) 1999-04-05
NZ503418A (en) 2001-02-23
EP1019063A4 (fr) 2003-09-03
NO20001341D0 (no) 2000-03-15
EP1019063A1 (fr) 2000-07-19
AU737867B2 (en) 2001-09-06
BR9812321A (pt) 2000-09-05

Similar Documents

Publication Publication Date Title
EP0196415B1 (fr) Trichostatines A et C comme agents anti-tumeurs
CA2078221C (fr) Compositions pharmaceutiques comprenant de la taurolidine et/ou du taurultam
Pratt Response of childhood rhabdomyosarcoma to combination chemotherapy
CA2431278A1 (fr) Methodes de traitement des troubles anxieux
Tawil et al. Acetazolamide‐induced nephrolithiasis: Implications for treatment of neuromuscular disorders
KR20020019914A (ko) 암치료용 ｅｔ743의 조성물 및 용도
CN1128615C (zh) 预防和治疗癌性疾病的药物组合物及其制备方法
EA001929B1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
ES2383005T3 (es) Medicamentos para enfermedades glomerulares
CN1279612A (zh) 免疫应答的调制
PL185678B1 (pl) Nowe zastosowanie dimeru lizozymu
RU2054288C1 (ru) Способ профилактики и лечения острых желудочно-кишечных болезней новорожденных телят
KR20040060958A (ko) 인터페론-γ 생산 촉진제
US3433875A (en) The improvement of mental performance with potassium n-acetyl dl aminosuccinate
RU2703723C1 (ru) Способ коррекции тревожно-депрессивных расстройств у больных с системными заболеваниями соединительной ткани
LV11524B (en) Use of benzydamine in the treatment of pathological conditions caused by tnf
CN1034133A (zh) 聚集在皮肤内的外用抗病毒药及其制备方法
JP2848634B2 (ja) 免疫抑制作用を有する医薬
JPH04202126A (ja) インターロイキン―１産生抑制剤
RU2166314C2 (ru) Лечебно-профилактическое средство "гексикон", обладающее антибактериальным и антисептическим действием
Kusum et al. A REVIEW ON SUSTAINED RELEASE TABLETS
RU2053765C1 (ru) Лекарственное средство для профилактики простудных заболеваний у детей
Talkov et al. The failure of cobra venom to relieve pain in rheumatoid arthritis
VAN WEZEL Purpura and Neutropenia in Trimethadione Therapy: Report of a Case with Recovery
RU2060730C1 (ru) Способ лечения острых желудочно-кишечных болезней новорожденных телят

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1031837

Country of ref document: HK